Martin Shkreli is back in the news today, as he has been removed as CEO from his second pharmaceutical company, California biotech firm KaloBios Pharmaceuticals.
Schkreli came under criticism this fall for dramatically hiking the price of a life-saving drug one of his companies, Turing Pharmaceuticals, acquired. The former drug company executive was also arrested last week for securities fraud, related to a hedge fund he ran years ago. Shkreli was removed the day after his arrest as CEO of Turing.
Jason Bellini of the Wall Street Journal joins Here & Now's Jeremy Hobson to discuss the latest news.
This segment aired on December 22, 2015.